INACTIVATED BACTERIAL PRODUCTS
- Section 113.100 - General requirements for inactivated bacterial products
- Section 113.101 - Leptospira Pomona Bacterin
- Section 113.102 - Leptospira Icterohaemorrhagiae Bacterin
- Section 113.103 - Leptospira Canicola Bacterin
- Section 113.104 - Leptospira Grippotyphosa Bacterin
- Section 113.105 - Leptospira Hardjo Bacterin
- Section 113.106 - Clostridium Chauvoei Bacterin
- Section 113.107 - Clostridium Haemolyticum Bacterin
- Section 113.108 - Clostridium Novyi Bacterin-Toxoid
- Section 113.109 - Clostridium Sordellii Bacterin-Toxoid
- Section 113.110 - Clostridium Botulinum Type C Bacterin-Toxoid
- Section 113.111 - Clostridium Perfringens Type C Toxoid and Bacterin-Toxoid
- Section 113.112 - Clostridium Perfringens Type D Toxoid and Bacterin-Toxoid
- Section 113.113 - Autogenous biologics
- Section 113.114 - Tetanus Toxoid
- Section 113.115 - Staphylococcus Aureus Bacterin-Toxoid
- Section 113.116 - Pasteurella Multocida Bacterin, Avian Isolate, Type 4
- Section 113.117 - Pasteurella Multocida Bacterin, Avian Isolate, Type 1
- Section 113.118 - Pasteurella Multocida Bacterin, Avian Isolate, Type 3
- Section 113.119 - Erysipelothrix Rhusiopathiae Bacterin
- Section 113.120 - Salmonella Typhimurium Bacterin
- Section 113.121 - Pasteurella Multocida Bacterin
- Section 113.122 - Salmonella Choleraesuis Bacterin
- Section 113.123 - Salmonella Dublin Bacterin